Literature DB >> 18307521

Impaired dendritic cell functions because of depletion of natural killer cells disrupt antigen-specific immune responses in mice: restoration of adaptive immunity in natural killer-depleted mice by antigen-pulsed dendritic cell.

O Yoshida1, F Akbar, T Miyake, M Abe, B Matsuura, Y Hiasa, M Onji.   

Abstract

The primary aim of this study was to evaluate the role of natural killer (NK) cells on antigen-specific adaptive immune responses. After analysing the mechanism of impaired adaptive immune responses of NK-depleted mice, an immune interventional approach was developed to restore adaptive immunity in NK-depleted mice. NK cells were depleted from mice by administration of anti-asialo GM1 antibody (100 mul/mouse), twice, at an interval of 48 h. Hepatitis B surface antigen (HBsAg) was administered intraperitoneally to normal C57BL/6 mice (control mice) and NK-depleted mice. The levels of antibody to HBsAg (anti-HBs) in the sera and HBsAg-specific lymphocytes in the spleen were assessed. The functions of T lymphocytes, B lymphocytes and dendritic cells (DCs) were evaluated in vitro. HBsAg-pulsed DCs were prepared by culturing spleen DCs with HBsAg for 48 h and administered once to NK-depleted mice. The levels of anti-HBs in the sera and HBsAg-specific lymphocytes were significantly lower in NK-depleted mice compared with control mice (P < 0.05). The functions of T and B lymphocytes were similar between control mice and NK-depleted mice. However, the functions of spleen DC and liver DC were significantly lower in NK-depleted mice compared with control mice (P < 0.05). Administration of HBsAg-pulsed DCs, but not HBsAg, induced HBsAg-specific humoral and cellular immune responses in NK-depleted mice. Our study suggests that cross-talk between NK cells and DCs regulates the magnitude of adaptive immunity. In addition, antigen-pulsed immunogenic DCs represent potent immune modulator even if subjects with diminished innate immunity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18307521      PMCID: PMC2384065          DOI: 10.1111/j.1365-2249.2008.03601.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Impaired dendritic cell function resulting from chronic undernutrition disrupts the antigen-specific immune response in mice.

Authors:  Tetsuji Niiya; Sk Md Fazle Akbar; Osamu Yoshida; Teruki Miyake; Bunzo Matsuura; Hidehiro Murakami; Masanori Abe; Yoichi Hiasa; Morikazu Onji
Journal:  J Nutr       Date:  2007-03       Impact factor: 4.798

2.  The role of CD11c(+) hepatic dendritic cells in the induction of innate immune responses.

Authors:  S-A Shu; Z-X Lian; Y-H Chuang; G-X Yang; Y Moritoki; S S Comstock; R-Q Zhong; A A Ansari; Y-J Liu; M E Gershwin
Journal:  Clin Exp Immunol       Date:  2007-05-22       Impact factor: 4.330

3.  Mechanism of action of vaccine therapy in murine hepatitis B virus carriers: vaccine-induced activation of antigen presenting dendritic cells.

Authors:  S M Akbar; M Abe; T Masumoto; N Horiike; M Onji
Journal:  J Hepatol       Date:  1999-05       Impact factor: 25.083

4.  In vivo ablation of CD11c-positive dendritic cells increases susceptibility to herpes simplex virus type 1 infection and diminishes NK and T-cell responses.

Authors:  Sadik H Kassim; Naveen K Rajasagi; Xiangyi Zhao; Robert Chervenak; Stephen R Jennings
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

5.  Impaired functional capacities of liver dendritic cells from murine hepatitis B virus (HBV) carriers: relevance to low HBV-specific immune responses.

Authors:  A Hasebe; S M F Akbar; S Furukawa; N Horiike; M Onji
Journal:  Clin Exp Immunol       Date:  2005-01       Impact factor: 4.330

Review 6.  Dendritic cell-based immunotherapy.

Authors:  Takuya Osada; Timothy M Clay; Christopher Y Woo; Michael A Morse; H Kim Lyerly
Journal:  Int Rev Immunol       Date:  2006 Sep-Dec       Impact factor: 5.311

Review 7.  Dendritic cell-based therapy as a multidisciplinary approach to cancer treatment: present limitations and future scopes.

Authors:  S M Fazle Akbar; Masanori Abe; Osamu Yoshida; Hidehiro Murakami; Morikazu Onji
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

8.  NK cells enhance dendritic cell response against parasite antigens via NKG2D pathway.

Authors:  Hongbing Guan; Magali Moretto; David J Bzik; Jason Gigley; Imtiaz A Khan
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

Review 9.  Innate versus adaptive immunity: a paradigm past its prime?

Authors:  Lisa Borghesi; Christine Milcarek
Journal:  Cancer Res       Date:  2007-05-01       Impact factor: 12.701

10.  Induction of anti-HBs in HB vaccine nonresponders in vivo by hepatitis B surface antigen-pulsed blood dendritic cells.

Authors:  Sk Md Fazle Akbar; Shinya Furukawa; Osamu Yoshida; Yoichi Hiasa; Norio Horiike; Morikazu Onji
Journal:  J Hepatol       Date:  2007-04-09       Impact factor: 25.083

View more
  9 in total

1.  Plasmid vector-linked maturation of natural killer (NK) cells is coupled to antigen-dependent NK cell activation during DNA-based immunization in mice.

Authors:  Ren Zhu; Maryline Mancini-Bourgine; Xiao Ming Zhang; Florence Bayard; Qiang Deng; Marie-Louise Michel
Journal:  J Virol       Date:  2011-07-20       Impact factor: 5.103

2.  Immunosuppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus.

Authors:  S Chen; S M F Akbar; M Abe; Y Hiasa; M Onji
Journal:  Clin Exp Immunol       Date:  2011-07-15       Impact factor: 4.330

3.  NK cells influence both innate and adaptive immune responses after mucosal immunization with antigen and mucosal adjuvant.

Authors:  Lindsay J Hall; Simon Clare; Gordon Dougan
Journal:  J Immunol       Date:  2010-03-10       Impact factor: 5.422

Review 4.  Natural killer cells in rejection and tolerance of solid organ allografts.

Authors:  Gilles Benichou; Yohei Yamada; Akihiro Aoyama; Joren C Madsen
Journal:  Curr Opin Organ Transplant       Date:  2011-02       Impact factor: 2.640

5.  Impaired dendritic cell functions disrupt antigen-specific adaptive immune responses in mice with nonalcoholic fatty liver disease.

Authors:  Teruki Miyake; Sheikh Mohammad Fazle Akbar; Osamu Yoshida; Shiyi Chen; Yoichi Hiasa; Bunzo Matsuura; Masanori Abe; Morikazu Onji
Journal:  J Gastroenterol       Date:  2010-03-02       Impact factor: 7.527

6.  Selection of allogeneic hematopoietic cell transplant donors to optimize natural killer cell alloreactivity.

Authors:  Brian C Shaffer; Katharine C Hsu
Journal:  Semin Hematol       Date:  2020-11-07       Impact factor: 3.851

7.  NK-dependent increases in CCL22 secretion selectively recruits regulatory T cells to the tumor microenvironment.

Authors:  Adam W Mailloux; M Rita I Young
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

8.  Innate immunity and resistance to tolerogenesis in allotransplantation.

Authors:  Gilles Benichou; Makoto Tonsho; Georges Tocco; Ognjenka Nadazdin; Joren C Madsen
Journal:  Front Immunol       Date:  2012-04-19       Impact factor: 7.561

9.  Rapid loss of group 1 innate lymphoid cells during blood stage Plasmodium infection.

Authors:  Susanna S Ng; Fernando Souza-Fonseca-Guimaraes; Fabian de Labastida Rivera; Fiona H Amante; Rajiv Kumar; Yulong Gao; Meru Sheel; Lynette Beattie; Marcela Montes de Oca; Camille Guillerey; Chelsea L Edwards; Rebecca J Faleiro; Teija Frame; Patrick T Bunn; Eric Vivier; Dale I Godfrey; Daniel G Pellicci; J Alejandro Lopez; Katherine T Andrews; Nicholas D Huntington; Mark J Smyth; James McCarthy; Christian R Engwerda
Journal:  Clin Transl Immunology       Date:  2018-01-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.